Full-Time

Country Head

Finance, Canada and Global Resilience FP&a

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Toronto, ON, Canada

70/30 work model requires 70% in-office presence.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
SAP Products
Requirements
  • MBA in Finance, Accounting, or Business Administration.
  • 11+ years of progressive commercial finance experience, with 7+ years within an international organization in a publicly held Life-Science/Healthcare industry.
  • Demonstrated experience in leading finance functions within complex, high-growth environments, particularly those involving collaboration across commercial and manufacturing operations.
  • Strong financial modeling skills and experience in building integrated financial models for large-scale operations.
  • Experience with SAP and other planning/reporting tools is essential.
  • Exceptional communication skills, with the ability to present complex financial information to senior management and stakeholders clearly and concisely.
  • Excellent English skills (both written and oral) as Moderna’s business language is in English.
  • Recognized accountancy qualification (e.g., CPA, ACA) and/or experience in a Big 4 public accounting firm preferred.
  • High degree of initiative and self-motivation, with the ability to deliver high-quality work under tight deadlines.
  • Strong organizational skills and attention to detail, with the ability to manage multiple priorities effectively.
Responsibilities
  • Develop and oversee finance processes in Canada, managing planning, reporting, and compliance.
  • Collaborate across commercial, R&D, manufacturing, and finance leadership to integrate financial strategies.
  • Engage with government entities to ensure regulatory compliance and manage contractual needs.
  • Lead financial stewardship, focusing on efficiency and compliance, driving financial innovation.
  • Drive annual budgeting and forecasting for the Commercial and Manufacturing teams in Canada.
  • Maintain a long-range financial plan focusing on value drivers and key investments.
  • Analyze financial performance versus plans, providing insights to optimize outcomes.
  • Identifying financial risks and opportunities in commercial and supply chain operations.
  • Supporting Resilience FP&A functions, ensuring alignment of budgeting and forecasting across sites.
  • Collaborating with the Global Controllership Organization to ensure financial compliance and enhance systems.
  • Managing all aspects of government contract compliance, including complex contract navigation.
  • Implementing and managing Moderna's financial controls framework in Canada.
  • Collaborating with the digital team to enhance finance systems and maintain relationships with local tax authorities.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?